InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026)
InfuSystem Holdings (INFU) posted Change in Accured Expenses of -$3.3 million for Q1 2026, down 478.78% on a QoQ basis from -$575000.0 in Q4 2025, and down 111.03% year-over-year from $30.2 million in Q1 2025.
InfuSystem Holdings (INFU) Change in Accured Expenses (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Change in Accured Expenses history runs 11 years deep, the most recent figure standing at -$3.3 million for Q1 2026.
- Quarterly Change in Accured Expenses fell 111.03% year-over-year to -$3.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 114.39% YoY) and the FY2025 annual result came in at -$708000.0, down 4.73% from the prior year.
- Change in Accured Expenses was -$3.3 million for Q1 2026 at InfuSystem Holdings, down from -$575000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $2.7 million in Q4 2023 and bottomed at -$3.3 million in Q1 2026.
- A 5-year average of $37941.2 and a median of $313000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 194.16% — and 2024, when it sank 453.35%.
- InfuSystem Holdings' Change in Accured Expenses stood at $1.7 million in 2022, then soared by 55.22% to $2.7 million in 2023, then tumbled by 79.55% to $553000.0 in 2024, then plunged by 203.98% to -$575000.0 in 2025, then tumbled by 478.78% to -$3.3 million in 2026.
- Business Quant data shows INFU's Change in Accured Expenses at -$3.3 million in Q1 2026, -$575000.0 in Q4 2025, and $1.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | -3.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.33 Mn |
| Mar 31, 2026 | -3.33 Mn |
| Dec 31, 2025 | -575,000.00 |
| Dec 31, 2025 | -575,000.00 |
| Sep 30, 2025 | 1.84 Mn |
| Sep 30, 2025 | 1.84 Mn |
| Jun 30, 2025 | -398,000.00 |
| Jun 30, 2025 | -398,000.00 |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | 553,000.00 |
| Dec 31, 2024 | 553,000.00 |
| Sep 30, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | -2.16 Mn |
| Jun 30, 2024 | -2.16 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | 2.70 Mn |
| Dec 31, 2023 | 2.70 Mn |